Retrospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 7, 2014; 20(45): 17132-17140
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17132
Figure 2
Figure 2 Prediction of recurrence and survival using the new scoring system. Our new scoring system is based on the alpha fetoprotein (AFP) of 100 ng/mL, standardized uptake values (SUVs) on positron emission tomography-computed tomography (PET-CT) of 3.5 and relative enhancement ratio (RER) on magnetic resonance imaging (MRI) of 0.6. We then summed the scores. A: Disease free survival of all population; B: Overall survival of all population; C: Disease free survival in those with tumor size less than 5 cm; D: Overall survival in those with tumor size less than 5 cm; E: Disease free survival in those with tumor size more than 5 cm; F: Overall survival in those with tumor size more than 5 cm.